1. Home
  2. STSS vs CTSO Comparison

STSS vs CTSO Comparison

Compare STSS & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sharps Technology Inc.

STSS

Sharps Technology Inc.

HOLD

Current Price

$1.74

Market Cap

43.8M

Sector

Health Care

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.59

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STSS
CTSO
Founded
2017
1997
Country
United States
United States
Employees
55
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
38.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
STSS
CTSO
Price
$1.74
$0.59
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
390.9K
108.2K
Earning Date
04-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$12.21
Revenue Next Year
N/A
$20.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.02
$0.50
52 Week High
$18.23
$1.39

Technical Indicators

Market Signals
Indicator
STSS
CTSO
Relative Strength Index (RSI) 52.29 39.78
Support Level $1.66 $0.50
Resistance Level $2.02 $0.74
Average True Range (ATR) 0.11 0.06
MACD 0.02 0.00
Stochastic Oscillator 83.33 41.26

Price Performance

Historical Comparison
STSS
CTSO

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: